A Feasibility Study of Brief Cognitive Behaviour Therapy for Adolescent OCD in Routine Clinical Practice
Led by University of Oxford · Updated on 2025-05-21
25
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
Obsessive-Compulsive Disorder (OCD) is a common and often disabling condition in young people, marked by distressing and repetitive thoughts and behaviors. This research aims to explore the delivery of a brief cognitive behavioral therapy (CBT) for adolescents aged 11 to 18 years with OCD within routine NHS child and adolescent mental health services (CAMHS). The study focuses on whether this brief CBT approach is feasible, acceptable, and effective, including for young people with co-occurring autism or high autistic traits.
The intervention involves five core face-to-face CBT sessions lasting 60 to 90 minutes each, with an option for two additional booster sessions over 24 weeks. These sessions are delivered by trained clinicians in NHS settings and supported by co-designed workbooks completed by the young person between sessions. Parents or carers also receive a workbook to support the young person's progress. Sessions start weekly and become less frequent over time, focusing on understanding OCD, goal setting, cognitive flexibility, and behavioral experiments. Involvement of parents and other adults is encouraged to help apply learning in daily life.
Participants will engage in assessments at baseline, post-treatment (12 weeks), and 3-month follow-up (24 weeks), including interviews, questionnaires, and routine clinical measures of OCD symptoms, anxiety, and depression. Clinician adherence and treatment acceptability will be monitored through session attendance, engagement, and feedback from young people, parents/carers, and clinicians. Qualitative interviews will assess experiences, and data will be analyzed to explore changes in symptoms and treatment processes, including for those with autism. The study runs from May 2025 to March 2026 with 20 to 30 young people and 8 to 10 clinicians involved.
CONDITIONS
Brief Title
Brief Cognitive Behaviour Therapy (CBT) for Adolescent OCD in Routine Clinical Practice
Who Can Participate
Age: 11Years - 18Years
All Genders
Eligibility Criteria
You may qualify if you...
Young people aged 11 to 18 years at recruitment
Diagnosed with OCD as the primary problem using the Anxiety Disorders Interview Schedule (ADIS)
Willing and able to give informed assent (if aged 11-15) or consent (if aged 16-18)
Stable dose of pharmacotherapy for OCD for at least 6 weeks before trial entry (if applicable)
Able to speak and read English sufficiently to use the workbooks and complete exercises
Willing to engage in treatment and comply with trial requirements
Willing to allow notification of their General Practitioner and consultant about participation
Parents/carers able and willing to provide consent and participate
Clinicians must have relevant psychological therapy qualifications including CBT training and approval to participate
You will not qualify if you...
Risk or safeguarding concerns that cannot be safely managed within the service
Any other significant disease or disorder that may pose risk or affect participation or trial results
Learning difficulties that would prevent participation in cognitive therapy components
Currently receiving psychological treatment for OCD
No exclusion criteria for parents/carers or clinicians
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - Up to 6 months prior to enrolment
Participants are screened for eligibility to participate in the trial.
1 eligibility assessment visit (part of routine clinical service)
Treatment
Duration - Up to 24 weeks
Participants receive brief Cognitive Behavioural Therapy (CBT) for OCD consisting of 5 sessions of 60 to 90 minutes, with an option of 2 additional booster sessions, delivered over a total of 24 weeks. Participants complete therapy workbooks, home tasks, and routine outcome measures during this period.
5 to 7 therapy sessions (in-person or via routine clinical services) plus additional home-based activities
Follow-up
Duration - Up to 12 weeks after treatment ends
Participants complete self-report questionnaires and clinical interviews at 3 months post-treatment to assess treatment outcomes, with some participants invited to participate in qualitative interviews.
2 assessment visits (in-person or remote) during follow-up period
Childhood, adolescent and adult age at onset and related clinical correlates in obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS).
Bernardo Dell'Osso, Beatrice Benatti, Eric Hollander...